News summary

Genetic Susceptibility and Clinical Validation of ICAM-5 in Immune-Mediated Non-infectious Uveitis

Source: Frontiers - Health • Published: 11 Sept 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Genetic, proteomic, transcriptomic, and retinal single-cell analyses converge on ICAM-5 as a candidate mediator and circulating biomarker for immune-mediated non-infectious uveitis.

Genetic Susceptibility and Clinical Validation of ICAM-5 in Immune-Mediated Non-infectious Uveitis
Key Takeaways
  • Mendelian randomization linked higher genetically predicted ICAM5 expression and protein levels to increased uveitis risk with significant odds ratios.
  • Plasma ICAM-5 concentrations were elevated in three uveitis subgroups versus healthy controls after age and sex adjustment.
  • Retinal single-cell RNA-sequencing localized Icam5 expression mainly to neuronal populations while blood transcriptomics showed increased ICAM5 in cases.
Read the full article at Frontiers - Health

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.